跳至主要内容
临床试验/NCT01546805
NCT01546805Unknown不适用

The Effect of Zinc Supplementation on the Efficacy and Duration of Botulinum Toxin for the Treatment of Oculofacial Spasm Disorders

St. Joseph's Healthcare Hamilton2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
Jankovic Rating Scale

研究概览

简要总结

The purpose of this study is to determine whether zinc supplements are effective in enhancing the treatment of oculofacial spasm disorders with botulinum toxin.

详细描述

Botulinum Toxin (Botox) has been used for many years in the treatment of oculofacial dystonias such as blepharospasm and hemifacial spasm. It has also gained widespread use for cosmetic purposes. The efficacy and duration of its effect is not constant amongst all patients. Some patient respond very well, while others have no clinical benefit or the clinical benefit does not last as long as expected. Zinc is known to be an important co-factor in the molecular effects of Botox. The investigators hypothesize that one of the many factors that may contribute to the variability in the response to Botox may be the level of Zinc available within the neuromuscular junction of those patients. The investigators plan to to test whether or not giving patients supplemental Zinc with their Botox injections would help improve the magnitude and duration of the intended clinical effect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • greater than the age 18 years old
  • patient with hemifacial spasm
  • patient with benign essential blepharospasm.

排除标准

  • patients who have received Botox within 3 months time,
  • patients prone to malabsorption (i.e. those with Celiac disease, inflammatory bowel disease, liver disease, laxative use)
  • patients who cannot tolerate zinc supplementation due to kidney disease, gastrointestinal disease, or any other medical condition.

研究组 & 干预措施

Placebo

Placebo Comparator

干预措施: Sugar pill (Drug)

Zinc Group

Experimental

干预措施: Zinc Supplement (Drug)

结局指标

主要结局

Jankovic Rating Scale

时间窗: 3 months post Botox injection

a well established scale used in the literature to grade the symptoms of patients with facial spasms disorders.

次要结局

  • Treatment Duration Cycle(The time frame will vary with each patient. The time frame is in fact the outcome measure being measured. On average the Botox treatment cycles last 3 months, however this average may be affected by zinc supplements.)
  • Blepharospasm Disability Index (BDI)(3 months post Botox injection)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验